{"gene":"FCHSD2","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2013,"finding":"FCHSD2 interacts with WASP and N-WASP and stimulates ARP2/3-dependent F-actin assembly in vitro; FCHSD2 localizes along stereocilia of cochlear hair cells in a punctate pattern","method":"Co-immunoprecipitation/pulldown, in vitro actin polymerization assay, immunofluorescence localization","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution of actin polymerization plus binding assays, replicated in subsequent studies","pmids":["23437151"],"is_preprint":false},{"year":2018,"finding":"ERK1/2 phosphorylates and activates FCHSD2, and this phosphorylation is required for FCHSD2-dependent clathrin-coated pit (CCP) initiation and clathrin-mediated endocytosis (CME) in NSCLC cancer cells; loss of FCHSD2 increases EGFR cell-surface expression and alters downstream signaling, enhancing cell proliferation and migration","method":"Kinase inhibitor screen, identification of ERK1/2 substrate by mass spectrometry/biochemical assay, siRNA knockdown with live-cell imaging of CCPs, EGFR trafficking assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (kinase substrate identification, CCP imaging, loss-of-function phenotypes) in a single study","pmids":["30249660"],"is_preprint":false},{"year":2020,"finding":"FCHSD2 loss shunts EGFR and MET trafficking from recycling into late endosomes/lysosomal degradation, causing nuclear translocation of active ERK1/2 and transcriptional upregulation of EGFR and MET; Rab7 is required for these FCHSD2-depletion-induced effects","method":"siRNA knockdown, receptor trafficking assays (recycling vs. degradation), subcellular fractionation, epistasis with Rab7 knockdown","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including epistasis with Rab7, trafficking assays, nuclear ERK measurements","pmids":["32678845"],"is_preprint":false},{"year":2021,"finding":"FCHSD2 promotes apical and lateral cell protrusion formation by cooperating with CDC42 and N-WASP; FCHSD2, CDC42, and N-WASP form a ternary complex; the F-BAR domain of FCHSD2 independently induces lateral protrusions; plasma membrane binding by FCHSD2 is required for protrusion induction","method":"Co-immunoprecipitation, overexpression/loss-of-function in cultured cells, domain-deletion mutant analysis, cell morphology assays","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2–3 — co-IP ternary complex and domain mutant analysis in a single lab study","pmids":["34520816"],"is_preprint":false},{"year":2022,"finding":"FCHSD2 is required for stereocilia maintenance in cochlear hair cells in vivo; Fchsd2 knockout mice show progressive hearing loss and increased acoustic vulnerability; Fchsd2/Cdc42 double knockout shows more severe stereocilia deficits, demonstrating cooperative regulation of stereocilia maintenance","method":"Fchsd2 knockout mouse generation, auditory brainstem response (ABR) hearing tests, electron microscopy of stereocilia, double KO epistasis","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — clean KO mouse with defined phenotype plus genetic epistasis with Cdc42","pmids":["35892293"],"is_preprint":false},{"year":2022,"finding":"FCHSD2 C-terminal PDZ-binding motif directly binds the PDZ3 domain of deafness-related protein PDZD7; crystal structure of the complex solved at 2.0 Å reveals the FCHSD2 tail threading through the αB/βB groove of PDZD7 PDZ3, linking the ankle link complex to cytoskeletal dynamics","method":"Yeast two-hybrid screening, co-immunoprecipitation in COS-7 cells, X-ray crystallography at 2.0 Å","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with atomic resolution plus biochemical validation","pmids":["35695292"],"is_preprint":false},{"year":2024,"finding":"MICAL-L1 (endosomal scaffolding protein) directly recruits FCHSD2 to the endosomal membrane, where FCHSD2 is required for ARP2/3-mediated branched actin generation, endosome fission, and receptor recycling to the plasma membrane; MICAL-L1 subsequently recruits EHD1 for nucleotide hydrolysis-based fission, placing FCHSD2 upstream of EHD1 in the endosomal fission pathway","method":"Co-immunoprecipitation identifying MICAL-L1–FCHSD2 interaction, siRNA knockdown of FCHSD2, live-cell imaging of endosome fission and recycling, epistasis between MICAL-L1, FCHSD2, and EHD1","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, KD with defined functional readouts, pathway epistasis in a single study","pmids":["39382837"],"is_preprint":false},{"year":2021,"finding":"FCHSD2 is an additional transcriptional target of an enhancer cluster at the STARD10/T2D locus; CRISPR-Cas9 loss of FCHSD2 in EndoC-βH1 cells impairs glucose-stimulated insulin secretion","method":"CRISPR-Cas9 deletion, glucose-stimulated insulin secretion assay, chromatin conformation capture","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — clean CRISPR KO with specific functional readout, single study","pmids":["33535042"],"is_preprint":false}],"current_model":"FCHSD2 is an F-BAR/SH3 domain scaffold protein that promotes ARP2/3-mediated actin polymerization by interacting with N-WASP and CDC42; it is activated by ERK1/2 phosphorylation to drive clathrin-coated pit initiation and CME, and is recruited to endosomal membranes by MICAL-L1 to generate branched actin required for endosome fission and receptor recycling; in hair cells, FCHSD2 cooperates with CDC42 to maintain stereocilia integrity, and its C-terminal PDZ-binding motif directly engages PDZD7 PDZ3 to connect the ankle link complex to cytoskeletal dynamics."},"narrative":{"teleology":[{"year":2013,"claim":"Establishing that FCHSD2 is an actin regulatory scaffold answered the foundational question of what its SH3 domains do: they recruit WASP/N-WASP to activate ARP2/3-dependent actin polymerization, and the protein localizes to stereocilia, implicating it in inner ear biology.","evidence":"In vitro actin polymerization reconstitution with purified proteins plus co-IP and immunofluorescence in cochlear hair cells","pmids":["23437151"],"confidence":"High","gaps":["No in vivo loss-of-function data at this stage","Upstream activation signals unknown","Cellular function of FCHSD2-dependent actin polymerization unresolved"]},{"year":2018,"claim":"Identifying ERK1/2 as the kinase that phosphorylates and activates FCHSD2 resolved how receptor signaling feeds back to the endocytic machinery: activated FCHSD2 drives clathrin-coated pit initiation, making it a direct link between MAPK signaling and clathrin-mediated endocytosis.","evidence":"Kinase inhibitor screen and mass spectrometry substrate identification in NSCLC cells, live-cell CCP imaging, EGFR surface-level quantification upon siRNA knockdown","pmids":["30249660"],"confidence":"High","gaps":["Phosphorylation site(s) and structural consequences not fully defined","Whether other kinases contribute is untested","Generality beyond EGFR/NSCLC context unclear"]},{"year":2020,"claim":"Demonstrating that FCHSD2 loss reroutes EGFR and MET from recycling into Rab7-dependent lysosomal degradation, with compensatory transcriptional upregulation via nuclear ERK, established FCHSD2 as a gatekeeper of receptor fate decisions at the sorting endosome.","evidence":"siRNA knockdown with receptor recycling/degradation assays, subcellular ERK fractionation, epistasis with Rab7 knockdown","pmids":["32678845"],"confidence":"High","gaps":["Direct biochemical mechanism by which FCHSD2 diverts cargo from degradation to recycling not resolved","Whether FCHSD2 acts at sorting endosomes or earlier compartments is ambiguous"]},{"year":2021,"claim":"Showing that FCHSD2 forms a ternary complex with CDC42 and N-WASP and that the F-BAR domain independently drives membrane protrusions clarified how domain architecture couples membrane binding to Rho-GTPase-dependent actin remodeling at the plasma membrane.","evidence":"Co-IP of ternary complex, domain-deletion mutant morphology assays in cultured cells","pmids":["34520816"],"confidence":"Medium","gaps":["Ternary complex shown in a single lab; independent validation lacking","Stoichiometry and direct vs. indirect interactions within the complex not resolved","Relevance of protrusions to endocytosis or other physiological contexts unclear"]},{"year":2021,"claim":"Identifying FCHSD2 as a target of a type 2 diabetes-associated enhancer cluster and showing that its CRISPR knockout impairs glucose-stimulated insulin secretion extended FCHSD2 function to pancreatic β-cell physiology.","evidence":"CRISPR-Cas9 knockout in EndoC-βH1 cells, glucose-stimulated insulin secretion assay, chromatin conformation capture","pmids":["33535042"],"confidence":"Medium","gaps":["Mechanism linking FCHSD2 to insulin granule exocytosis unknown","No in vivo β-cell phenotype reported","Whether the endocytic/recycling role explains the insulin secretion defect is untested"]},{"year":2022,"claim":"Fchsd2 knockout mice with progressive hearing loss and genetic epistasis with Cdc42 provided the first in vivo demonstration that FCHSD2–CDC42 cooperation is essential for stereocilia structural maintenance, converting earlier localization data into a physiological requirement.","evidence":"Fchsd2 KO and Fchsd2/Cdc42 double KO mice, ABR hearing tests, electron microscopy of stereocilia","pmids":["35892293"],"confidence":"High","gaps":["Whether FCHSD2 acts through N-WASP/ARP2/3 in stereocilia or via a distinct mechanism is unresolved","Precise structural defect in actin core of stereocilia not characterized"]},{"year":2022,"claim":"A 2.0 Å crystal structure of the FCHSD2 C-terminal tail bound to PDZD7 PDZ3 revealed the atomic basis for coupling the ankle link complex to the cytoskeleton, providing a structural explanation for how FCHSD2 integrates into the hair-cell mechanotransduction apparatus.","evidence":"X-ray crystallography, yeast two-hybrid, co-IP validation in COS-7 cells","pmids":["35695292"],"confidence":"High","gaps":["Functional consequence of disrupting the FCHSD2–PDZD7 interaction in vivo not tested","Whether PDZD7 binding modulates FCHSD2 actin-regulatory activity is unknown"]},{"year":2024,"claim":"Demonstrating that MICAL-L1 recruits FCHSD2 to endosomes for ARP2/3-dependent branched actin generation upstream of EHD1-mediated fission resolved the molecular order of events in endosomal recycling and identified the mechanism by which FCHSD2 acts in receptor recycling.","evidence":"Reciprocal co-IP, siRNA knockdown with live-cell endosome fission imaging, epistasis between MICAL-L1, FCHSD2, and EHD1","pmids":["39382837"],"confidence":"High","gaps":["How MICAL-L1 recognizes FCHSD2 at the domain level is undefined","Whether F-BAR-mediated membrane tubulation by FCHSD2 contributes to fission is untested"]},{"year":null,"claim":"Major unresolved questions include the structural basis of ERK1/2-mediated FCHSD2 activation, whether FCHSD2's endocytic and recycling roles explain its requirement for insulin secretion, and the extent to which its stereocilia and endosomal functions share a common ARP2/3-dependent mechanism.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of full-length FCHSD2 or its F-BAR domain","ERK phosphorylation site mapping and conformational activation mechanism incomplete","Relationship between endocytic/recycling function and β-cell insulin secretion untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,3,4,6]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,3,6]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2,6]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,4]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,2,6]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2]},{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[4,5]}],"complexes":[],"partners":["WASL","CDC42","PDZD7","MICAL-L1","EHD1","WAS"],"other_free_text":[]},"mechanistic_narrative":"FCHSD2 is an F-BAR and SH3 domain-containing scaffold protein that couples membrane curvature sensing to ARP2/3-dependent actin polymerization, functioning in clathrin-mediated endocytosis, endosomal recycling, and specialized cytoskeletal maintenance. FCHSD2 forms a ternary complex with CDC42 and N-WASP to stimulate branched actin assembly; ERK1/2-mediated phosphorylation activates FCHSD2 to promote clathrin-coated pit initiation, and its loss redirects EGFR and MET from recycling into lysosomal degradation, altering downstream signaling [PMID:23437151, PMID:30249660, PMID:32678845, PMID:34520816]. At endosomes, MICAL-L1 recruits FCHSD2 to generate ARP2/3-dependent branched actin required for endosome fission and receptor recycling upstream of EHD1 [PMID:39382837]. In cochlear hair cells, FCHSD2 cooperates with CDC42 to maintain stereocilia integrity—Fchsd2 knockout mice exhibit progressive hearing loss—and its C-terminal PDZ-binding motif directly engages the PDZ3 domain of the deafness-associated protein PDZD7, physically connecting the ankle link complex to the actin cytoskeleton [PMID:35892293, PMID:35695292]."},"prefetch_data":{"uniprot":{"accession":"O94868","full_name":"F-BAR and double SH3 domains protein 2","aliases":["Carom","Protein nervous wreck 1","NWK1","SH3 multiple domains protein 3"],"length_aa":740,"mass_kda":84.3,"function":"Adapter protein that plays a role in endocytosis via clathrin-coated pits. Contributes to the internalization of cell surface receptors, such as integrin ITGB1 and transferrin receptor (PubMed:29887380). Promotes endocytosis of EGFR in cancer cells, and thereby contributes to the down-regulation of EGFR signaling (PubMed:30249660). Recruited to clathrin-coated pits during a mid-to-late stage of assembly, where it is required for normal progress from U-shaped intermediate stage pits to terminal, omega-shaped pits (PubMed:29887380). Binds to membranes enriched in phosphatidylinositol 3,4-bisphosphate or phosphatidylinositol 3,4,5-trisphosphate (PubMed:29887380). When bound to membranes, promotes actin polymerization via its interaction with WAS and/or WASL which leads to the activation of the Arp2/3 complex. Does not promote actin polymerisation in the absence of membranes (PubMed:29887380)","subcellular_location":"Cytoplasm; Cell junction; Membrane, clathrin-coated pit; Cell membrane; Cell projection, stereocilium","url":"https://www.uniprot.org/uniprotkb/O94868/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FCHSD2","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000137478","cell_line_id":"CID000664","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"membrane","grade":2},{"compartment":"cell_contact","grade":1}],"interactors":[],"url":"https://opencell.sf.czbiohub.org/target/CID000664","total_profiled":1310},"omim":[{"mim_id":"619714","title":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT; CDG1WAD","url":"https://www.omim.org/entry/619714"},{"mim_id":"617556","title":"FCH AND DOUBLE SH3 DOMAINS PROTEIN 2; FCHSD2","url":"https://www.omim.org/entry/617556"},{"mim_id":"617555","title":"FCH AND DOUBLE SH3 DOMAINS PROTEIN 1; FCHSD1","url":"https://www.omim.org/entry/617555"},{"mim_id":"615596","title":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL RECESSIVE; CDG1WAR","url":"https://www.omim.org/entry/615596"},{"mim_id":"611565","title":"BRIDGE-LIKE LIPID TRANSFER PROTEIN FAMILY, MEMBER 1; BLTP1","url":"https://www.omim.org/entry/611565"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Actin filaments","reliability":"Approved"},{"location":"Nuclear speckles","reliability":"Additional"},{"location":"Focal adhesion sites","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/FCHSD2"},"hgnc":{"alias_symbol":["KIAA0769"],"prev_symbol":["SH3MD3"]},"alphafold":{"accession":"O94868","domains":[{"cath_id":"1.20.1270.60","chopping":"18-268","consensus_level":"medium","plddt":92.8315,"start":18,"end":268},{"cath_id":"2.30.30.40","chopping":"471-529","consensus_level":"high","plddt":86.1854,"start":471,"end":529},{"cath_id":"2.30.30.40","chopping":"570-626","consensus_level":"high","plddt":83.0344,"start":570,"end":626},{"cath_id":"1.20.58","chopping":"318-422","consensus_level":"high","plddt":87.5899,"start":318,"end":422}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O94868","model_url":"https://alphafold.ebi.ac.uk/files/AF-O94868-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O94868-F1-predicted_aligned_error_v6.png","plddt_mean":74.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FCHSD2","jax_strain_url":"https://www.jax.org/strain/search?query=FCHSD2"},"sequence":{"accession":"O94868","fasta_url":"https://rest.uniprot.org/uniprotkb/O94868.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O94868/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O94868"}},"corpus_meta":[{"pmid":"23437151","id":"PMC_23437151","title":"FCHSD1 and FCHSD2 are expressed in hair cell stereocilia and cuticular plate and regulate actin polymerization in vitro.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23437151","citation_count":34,"is_preprint":false},{"pmid":"15067381","id":"PMC_15067381","title":"Identification and characterization of human FCHSD1 and FCHSD2 genes in silico.","date":"2004","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15067381","citation_count":33,"is_preprint":false},{"pmid":"30249660","id":"PMC_30249660","title":"Role for ERK1/2-dependent activation of FCHSD2 in cancer cell-selective regulation of clathrin-mediated endocytosis.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30249660","citation_count":33,"is_preprint":false},{"pmid":"32678845","id":"PMC_32678845","title":"FCHSD2 controls oncogenic ERK1/2 signaling outcome by regulating endocytic trafficking.","date":"2020","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/32678845","citation_count":15,"is_preprint":false},{"pmid":"22902056","id":"PMC_22902056","title":"FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients.","date":"2012","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/22902056","citation_count":9,"is_preprint":false},{"pmid":"33535042","id":"PMC_33535042","title":"Chromatin 3D interaction analysis of the STARD10 locus unveils FCHSD2 as a regulator of insulin secretion.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33535042","citation_count":8,"is_preprint":false},{"pmid":"34520816","id":"PMC_34520816","title":"FCHSD2 cooperates with CDC42 and N-WASP to regulate cell protrusion formation.","date":"2021","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34520816","citation_count":7,"is_preprint":false},{"pmid":"35892293","id":"PMC_35892293","title":"FCHSD2 is required for stereocilia maintenance in mouse cochlear hair cells.","date":"2022","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/35892293","citation_count":3,"is_preprint":false},{"pmid":"35695292","id":"PMC_35695292","title":"Deafness-related protein PDZD7 forms complex with the C-terminal tail of FCHSD2.","date":"2022","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/35695292","citation_count":2,"is_preprint":false},{"pmid":"39382837","id":"PMC_39382837","title":"Endosomal actin branching, fission, and receptor recycling require FCHSD2 recruitment by MICAL-L1.","date":"2024","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/39382837","citation_count":2,"is_preprint":false},{"pmid":"38979241","id":"PMC_38979241","title":"Endosomal actin branching, fission and receptor recycling require FCHSD2 recruitment by MICAL-L1.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38979241","citation_count":0,"is_preprint":false},{"pmid":"37224049","id":"PMC_37224049","title":"IRF3-mediated lncRNA FTX promotes cell proliferation, migration, invasion and suppresses cell apoptosis in oral squamous cell carcinoma by up-regulating FCHSD2 via miR-708-5p.","date":"2023","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/37224049","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7500,"output_tokens":2049,"usd":0.026617},"stage2":{"model":"claude-opus-4-6","input_tokens":5347,"output_tokens":2605,"usd":0.13779},"total_usd":0.164407,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"FCHSD2 interacts with WASP and N-WASP and stimulates ARP2/3-dependent F-actin assembly in vitro; FCHSD2 localizes along stereocilia of cochlear hair cells in a punctate pattern\",\n      \"method\": \"Co-immunoprecipitation/pulldown, in vitro actin polymerization assay, immunofluorescence localization\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution of actin polymerization plus binding assays, replicated in subsequent studies\",\n      \"pmids\": [\"23437151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ERK1/2 phosphorylates and activates FCHSD2, and this phosphorylation is required for FCHSD2-dependent clathrin-coated pit (CCP) initiation and clathrin-mediated endocytosis (CME) in NSCLC cancer cells; loss of FCHSD2 increases EGFR cell-surface expression and alters downstream signaling, enhancing cell proliferation and migration\",\n      \"method\": \"Kinase inhibitor screen, identification of ERK1/2 substrate by mass spectrometry/biochemical assay, siRNA knockdown with live-cell imaging of CCPs, EGFR trafficking assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (kinase substrate identification, CCP imaging, loss-of-function phenotypes) in a single study\",\n      \"pmids\": [\"30249660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FCHSD2 loss shunts EGFR and MET trafficking from recycling into late endosomes/lysosomal degradation, causing nuclear translocation of active ERK1/2 and transcriptional upregulation of EGFR and MET; Rab7 is required for these FCHSD2-depletion-induced effects\",\n      \"method\": \"siRNA knockdown, receptor trafficking assays (recycling vs. degradation), subcellular fractionation, epistasis with Rab7 knockdown\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including epistasis with Rab7, trafficking assays, nuclear ERK measurements\",\n      \"pmids\": [\"32678845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FCHSD2 promotes apical and lateral cell protrusion formation by cooperating with CDC42 and N-WASP; FCHSD2, CDC42, and N-WASP form a ternary complex; the F-BAR domain of FCHSD2 independently induces lateral protrusions; plasma membrane binding by FCHSD2 is required for protrusion induction\",\n      \"method\": \"Co-immunoprecipitation, overexpression/loss-of-function in cultured cells, domain-deletion mutant analysis, cell morphology assays\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — co-IP ternary complex and domain mutant analysis in a single lab study\",\n      \"pmids\": [\"34520816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FCHSD2 is required for stereocilia maintenance in cochlear hair cells in vivo; Fchsd2 knockout mice show progressive hearing loss and increased acoustic vulnerability; Fchsd2/Cdc42 double knockout shows more severe stereocilia deficits, demonstrating cooperative regulation of stereocilia maintenance\",\n      \"method\": \"Fchsd2 knockout mouse generation, auditory brainstem response (ABR) hearing tests, electron microscopy of stereocilia, double KO epistasis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mouse with defined phenotype plus genetic epistasis with Cdc42\",\n      \"pmids\": [\"35892293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FCHSD2 C-terminal PDZ-binding motif directly binds the PDZ3 domain of deafness-related protein PDZD7; crystal structure of the complex solved at 2.0 Å reveals the FCHSD2 tail threading through the αB/βB groove of PDZD7 PDZ3, linking the ankle link complex to cytoskeletal dynamics\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation in COS-7 cells, X-ray crystallography at 2.0 Å\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with atomic resolution plus biochemical validation\",\n      \"pmids\": [\"35695292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MICAL-L1 (endosomal scaffolding protein) directly recruits FCHSD2 to the endosomal membrane, where FCHSD2 is required for ARP2/3-mediated branched actin generation, endosome fission, and receptor recycling to the plasma membrane; MICAL-L1 subsequently recruits EHD1 for nucleotide hydrolysis-based fission, placing FCHSD2 upstream of EHD1 in the endosomal fission pathway\",\n      \"method\": \"Co-immunoprecipitation identifying MICAL-L1–FCHSD2 interaction, siRNA knockdown of FCHSD2, live-cell imaging of endosome fission and recycling, epistasis between MICAL-L1, FCHSD2, and EHD1\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, KD with defined functional readouts, pathway epistasis in a single study\",\n      \"pmids\": [\"39382837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FCHSD2 is an additional transcriptional target of an enhancer cluster at the STARD10/T2D locus; CRISPR-Cas9 loss of FCHSD2 in EndoC-βH1 cells impairs glucose-stimulated insulin secretion\",\n      \"method\": \"CRISPR-Cas9 deletion, glucose-stimulated insulin secretion assay, chromatin conformation capture\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean CRISPR KO with specific functional readout, single study\",\n      \"pmids\": [\"33535042\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FCHSD2 is an F-BAR/SH3 domain scaffold protein that promotes ARP2/3-mediated actin polymerization by interacting with N-WASP and CDC42; it is activated by ERK1/2 phosphorylation to drive clathrin-coated pit initiation and CME, and is recruited to endosomal membranes by MICAL-L1 to generate branched actin required for endosome fission and receptor recycling; in hair cells, FCHSD2 cooperates with CDC42 to maintain stereocilia integrity, and its C-terminal PDZ-binding motif directly engages PDZD7 PDZ3 to connect the ankle link complex to cytoskeletal dynamics.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FCHSD2 is an F-BAR and SH3 domain-containing scaffold protein that couples membrane curvature sensing to ARP2/3-dependent actin polymerization, functioning in clathrin-mediated endocytosis, endosomal recycling, and specialized cytoskeletal maintenance. FCHSD2 forms a ternary complex with CDC42 and N-WASP to stimulate branched actin assembly; ERK1/2-mediated phosphorylation activates FCHSD2 to promote clathrin-coated pit initiation, and its loss redirects EGFR and MET from recycling into lysosomal degradation, altering downstream signaling [PMID:23437151, PMID:30249660, PMID:32678845, PMID:34520816]. At endosomes, MICAL-L1 recruits FCHSD2 to generate ARP2/3-dependent branched actin required for endosome fission and receptor recycling upstream of EHD1 [PMID:39382837]. In cochlear hair cells, FCHSD2 cooperates with CDC42 to maintain stereocilia integrity—Fchsd2 knockout mice exhibit progressive hearing loss—and its C-terminal PDZ-binding motif directly engages the PDZ3 domain of the deafness-associated protein PDZD7, physically connecting the ankle link complex to the actin cytoskeleton [PMID:35892293, PMID:35695292].\",\n  \"teleology\": [\n    {\n      \"year\": 2013,\n      \"claim\": \"Establishing that FCHSD2 is an actin regulatory scaffold answered the foundational question of what its SH3 domains do: they recruit WASP/N-WASP to activate ARP2/3-dependent actin polymerization, and the protein localizes to stereocilia, implicating it in inner ear biology.\",\n      \"evidence\": \"In vitro actin polymerization reconstitution with purified proteins plus co-IP and immunofluorescence in cochlear hair cells\",\n      \"pmids\": [\"23437151\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No in vivo loss-of-function data at this stage\", \"Upstream activation signals unknown\", \"Cellular function of FCHSD2-dependent actin polymerization unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying ERK1/2 as the kinase that phosphorylates and activates FCHSD2 resolved how receptor signaling feeds back to the endocytic machinery: activated FCHSD2 drives clathrin-coated pit initiation, making it a direct link between MAPK signaling and clathrin-mediated endocytosis.\",\n      \"evidence\": \"Kinase inhibitor screen and mass spectrometry substrate identification in NSCLC cells, live-cell CCP imaging, EGFR surface-level quantification upon siRNA knockdown\",\n      \"pmids\": [\"30249660\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation site(s) and structural consequences not fully defined\", \"Whether other kinases contribute is untested\", \"Generality beyond EGFR/NSCLC context unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that FCHSD2 loss reroutes EGFR and MET from recycling into Rab7-dependent lysosomal degradation, with compensatory transcriptional upregulation via nuclear ERK, established FCHSD2 as a gatekeeper of receptor fate decisions at the sorting endosome.\",\n      \"evidence\": \"siRNA knockdown with receptor recycling/degradation assays, subcellular ERK fractionation, epistasis with Rab7 knockdown\",\n      \"pmids\": [\"32678845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical mechanism by which FCHSD2 diverts cargo from degradation to recycling not resolved\", \"Whether FCHSD2 acts at sorting endosomes or earlier compartments is ambiguous\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showing that FCHSD2 forms a ternary complex with CDC42 and N-WASP and that the F-BAR domain independently drives membrane protrusions clarified how domain architecture couples membrane binding to Rho-GTPase-dependent actin remodeling at the plasma membrane.\",\n      \"evidence\": \"Co-IP of ternary complex, domain-deletion mutant morphology assays in cultured cells\",\n      \"pmids\": [\"34520816\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ternary complex shown in a single lab; independent validation lacking\", \"Stoichiometry and direct vs. indirect interactions within the complex not resolved\", \"Relevance of protrusions to endocytosis or other physiological contexts unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying FCHSD2 as a target of a type 2 diabetes-associated enhancer cluster and showing that its CRISPR knockout impairs glucose-stimulated insulin secretion extended FCHSD2 function to pancreatic β-cell physiology.\",\n      \"evidence\": \"CRISPR-Cas9 knockout in EndoC-βH1 cells, glucose-stimulated insulin secretion assay, chromatin conformation capture\",\n      \"pmids\": [\"33535042\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking FCHSD2 to insulin granule exocytosis unknown\", \"No in vivo β-cell phenotype reported\", \"Whether the endocytic/recycling role explains the insulin secretion defect is untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Fchsd2 knockout mice with progressive hearing loss and genetic epistasis with Cdc42 provided the first in vivo demonstration that FCHSD2–CDC42 cooperation is essential for stereocilia structural maintenance, converting earlier localization data into a physiological requirement.\",\n      \"evidence\": \"Fchsd2 KO and Fchsd2/Cdc42 double KO mice, ABR hearing tests, electron microscopy of stereocilia\",\n      \"pmids\": [\"35892293\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FCHSD2 acts through N-WASP/ARP2/3 in stereocilia or via a distinct mechanism is unresolved\", \"Precise structural defect in actin core of stereocilia not characterized\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A 2.0 Å crystal structure of the FCHSD2 C-terminal tail bound to PDZD7 PDZ3 revealed the atomic basis for coupling the ankle link complex to the cytoskeleton, providing a structural explanation for how FCHSD2 integrates into the hair-cell mechanotransduction apparatus.\",\n      \"evidence\": \"X-ray crystallography, yeast two-hybrid, co-IP validation in COS-7 cells\",\n      \"pmids\": [\"35695292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of disrupting the FCHSD2–PDZD7 interaction in vivo not tested\", \"Whether PDZD7 binding modulates FCHSD2 actin-regulatory activity is unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating that MICAL-L1 recruits FCHSD2 to endosomes for ARP2/3-dependent branched actin generation upstream of EHD1-mediated fission resolved the molecular order of events in endosomal recycling and identified the mechanism by which FCHSD2 acts in receptor recycling.\",\n      \"evidence\": \"Reciprocal co-IP, siRNA knockdown with live-cell endosome fission imaging, epistasis between MICAL-L1, FCHSD2, and EHD1\",\n      \"pmids\": [\"39382837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MICAL-L1 recognizes FCHSD2 at the domain level is undefined\", \"Whether F-BAR-mediated membrane tubulation by FCHSD2 contributes to fission is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the structural basis of ERK1/2-mediated FCHSD2 activation, whether FCHSD2's endocytic and recycling roles explain its requirement for insulin secretion, and the extent to which its stereocilia and endosomal functions share a common ARP2/3-dependent mechanism.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of full-length FCHSD2 or its F-BAR domain\", \"ERK phosphorylation site mapping and conformational activation mechanism incomplete\", \"Relationship between endocytic/recycling function and β-cell insulin secretion untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 3, 4, 6]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 3, 6]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2, 6]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 2, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"WASL\", \"CDC42\", \"PDZD7\", \"MICAL-L1\", \"EHD1\", \"WAS\"],\n    \"other_free_text\": []\n  }\n}\n```"}